10-K Decoder · All companies

Galectin Therapeutics Inc.

GALT · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$0K$0K
Operating income−$20.1M−$42.4M+52.7%
Net income−$30.8M−$47.0M+34.5%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 16, 2026

$Q3 2026Year earlierChange
Revenue$0K$0K
Operating income−$3.40M−$4.20M+19.0%
Net income−$3.50M−$8.20M+57.3%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Galectin's revenue in FY2025?
$0K in FY2025 (Fiscal year ended Dec 31, 2025), no comparable figure vs $0K a year earlier, per its 10-K filed Mar 2026.
Was Galectin profitable in FY2025?
No: net income was −$30.8M and operating income −$20.1M in FY2025.
What was Galectin's revenue in Q3 2026?
$0K (n/a vs a year earlier), per its Form 10-Q filed Nov 16, 2026.